Skin Cancer

LATEST NEWS

Calculated Tumor Area Has Prognostic Value for Melanoma

Stratification of melanoma into groups based on calculated tumor area improves prognostic value over stratification using the category based on Breslow thickness.

Overall Survival Worse With Multiple Primary Melanomas

Patients with multiple primary melanomas have worse overall survival than those with a single primary melanoma.

Lack of Confidence in Undertaking Skin Self-Examinations in Patients With Melanoma

By

Brandon May

Efforts to integrate new digital technologies to increase regular and thorough skin self-examination for patients with melanoma are warranted, provided sufficient technical support is provided.

Carbamazepine and Lamotrigine Associated With Increased Risk for SCC

By

Brandon May

A comparison of AEDs finds that while most were not associated with skin cancer, carbamazepine and lamotrigine were associated with squamous cell carcinoma.

How to Treat Melanoma After Checkpoint Inhibitors Fail

By

Agata Boxe

The combination of ipilimumab and nivolumab resulted in a higher rate of objective remissions compared with ipilimumab alone.

Ipilimumab, BRAF/MEK Inhibitors Are Active in Patients With Resected Melanoma Who Recurred on Adjuvant Anti–PD-1

By

Agata Boxe

For patients who recur on anti–PD-1, they should be considered resistant to anti–PD-1 and must change to a different type of medication, said Dr Owen.

Elevated Levels of Serum CRP and IL-6 Are Biomarkers of Poor Prognosis in Patients Receiving Immune Checkpoint Inhibitors

By

Susan Moench, PhD, PA-C

New data revealed an association between low baseline IL-6 level and improved survival in patients across all 3 arms of CheckMate 067.

Four Single Nucleotide Polymorphisms May Predict Non-Melanoma Skin Cancer Risk

By

Brandon May

Investigators sought to determine whether the presence of single nucleotide polymorphisms is a risk factor for non-melanoma skin cancer.

Access to Care Worse for Sexual-Minority Cancer Survivors

Sexual-minority cancer survivors have worse access to care and higher odds of poor quality of life.

Half-Time Photodynamic Therapy Effective and Safe for Actinic Keratosis

By

Dermatology Advisor Contributing Writer

Investigators examined the efficacy, tolerability, and safety of conventional methyl aminolevulinic acid photodynamic therapy and half-time conventional red light illumination in patients with multiple actinic keratosis.